From: Driving developments in UK oesophageal radiotherapy through the SCOPE trials
Structure name | Constraint | Optimal | Mandatory |
---|---|---|---|
PTV_6000 (High dose arm only) | V95% (57Gy) | >  95% | ≥ 90% |
 | Dmedian | 100% (60Gy) | The median should be between 98 and 102% of the prescription dose (i.e., 60Gy). |
PTV_5000 | V95% (47.5Gy) | >  95% | ≥ 90% |
 | Dmedian | 100% (50Gy, standard dose arm only) | The median should be between 98 and 102% of the prescription dose (i.e., 50Gy, standard dose arm only). |
External | D1.8 cc |  | < 107% of highest prescribed dose |
SpinalCord_PRV | D0.1 cc | < 40Gy | <  42 Gy |
Heart | Dmean | <  25Gy | <30Gy |
 | V30Gy | <  45% | - |
Lungs | Dmean | < 17Gy | <19Gy |
(Combined lungs) | V20Gy | <  20 | ≤25 |
Stomach_excl_PTV_5000 (Stomach excluding PTV_5000) | V50Gy | <  16 cc | <  25 cc |
Liver | Dmean | ≤28Gy | ≤30Gy |
V30Gy | V30Gy < 30% | - | |
Kidney_L and Kidney_R (Individual kidneys) | V20Gy | <  25% | ≤30% |